Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

707 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analytical interference with most current commercial HIV molecular assays in patients treated by idecabtagene vicleucel, a recently approved lentivirus-based chimeric antigen receptor T-cell therapy.
Pronier C, Stefic K, Le Guillou Guillemette H, Roussel M, Thibault V, Maillard A. Pronier C, et al. Among authors: roussel m. Clin Microbiol Infect. 2024 Feb;30(2):258-260. doi: 10.1016/j.cmi.2023.10.026. Epub 2023 Oct 31. Clin Microbiol Infect. 2024. PMID: 37918511 Free article. No abstract available.
Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registry.
Herbaux C, Bret C, Bachy E, Bories P, Di Blasi R, Cuffel A, Gastinne T, Lamy T, Roussel M, Bouabdallah K, Beauvais D, Cartron G, Bay JO, Blaise D, Rubio MT, Mohty M, Le Bras F, Casasnovas O, Guy J, Guidez S, Llorente CC, Hermine O, La Rochelle LD, Carras S, Guffroy B, Caillat-Zucman S, Houot R, Le Gouill S. Herbaux C, et al. Among authors: roussel m. Haematologica. 2024 Nov 1;109(11):3745-3750. doi: 10.3324/haematol.2023.284786. Haematologica. 2024. PMID: 38899352 Free PMC article. No abstract available.
Evaluation of Cereblon-Directing Warheads for the Development of Orally Bioavailable PROTACs.
Actis M, Cresser-Brown J, Caine EA, Steger M, Aggarwal A, Mayasundari A, Murphy N, Valinciute G, Li Y, Fu X, Yang L, Marsh G, Hughes G, Karadogan B, Wheeler D, Norley M, Spain F, Urh M, Roussel MF, Schwalb B, Daub H, Riching KM, Maple H, Nishiguchi G, Rankovic Z. Actis M, et al. Among authors: roussel mf. J Med Chem. 2025 Jan 15. doi: 10.1021/acs.jmedchem.4c02709. Online ahead of print. J Med Chem. 2025. PMID: 39813384
Elranatamab monotherapy in the real-word setting in relapsed-refractory multiple myeloma: results of the French compassionate use program on behalf of the IFM.
Malard F, Bobin A, Labopin M, Karlin L, Frenzel L, Roussel M, Vignon M, Godet S, Chalopin T, Moyer P, Chalayer E, Orsini Piocelle F, Mariette C, Croizier C, Sohn C, Dib M, Le Calloch R, Ali-Ammar N, Loirat M, Benbrahim O, Payssot A, Trebouet A, Perrot A, Leleu X, Mohty M. Malard F, et al. Among authors: roussel m. Blood Cancer J. 2024 Dec 18;14(1):219. doi: 10.1038/s41408-024-01200-w. Blood Cancer J. 2024. PMID: 39695076 Free PMC article. No abstract available.
Teclistamab in relapsed refractory multiple myeloma: a multi-institutional real-world study from the French early access program.
Perrot A, Hulin C, Boumendil A, Manjra H, Leveque A, Croizier C, Dony A, Mohty M, Roussel M, Manier S, Orsini-Piocelle F, Bauschert L, Bobin A, Frenzel L, Vincent L, Breal C, Eveillard JR, Gerome T, Tiab M, Chalayer E, Belkhir R, Mariette C, Moyer P, Chalopin T, Cherel B, Montes L, Coste A, Tabrizi R, Karlin L, Robu D, Huguet A, Harel S, Moreau P. Perrot A, et al. Among authors: roussel m. Haematologica. 2024 Nov 21. doi: 10.3324/haematol.2024.286118. Online ahead of print. Haematologica. 2024. PMID: 39568438 Free article.
707 results